NO955059L - Peptider som utviser oksytocin antagonistisk aktivitet - Google Patents

Peptider som utviser oksytocin antagonistisk aktivitet

Info

Publication number
NO955059L
NO955059L NO955059A NO955059A NO955059L NO 955059 L NO955059 L NO 955059L NO 955059 A NO955059 A NO 955059A NO 955059 A NO955059 A NO 955059A NO 955059 L NO955059 L NO 955059L
Authority
NO
Norway
Prior art keywords
antagonistic activity
peptides showing
abu
asn
mpa
Prior art date
Application number
NO955059A
Other languages
English (en)
Norwegian (no)
Other versions
NO955059D0 (no
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO955059D0 publication Critical patent/NO955059D0/no
Publication of NO955059L publication Critical patent/NO955059L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO955059A 1993-07-13 1995-12-13 Peptider som utviser oksytocin antagonistisk aktivitet NO955059L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
PCT/SE1994/000674 WO1995002609A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity

Publications (2)

Publication Number Publication Date
NO955059D0 NO955059D0 (no) 1995-12-13
NO955059L true NO955059L (no) 1995-12-13

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955059A NO955059L (no) 1993-07-13 1995-12-13 Peptider som utviser oksytocin antagonistisk aktivitet

Country Status (16)

Country Link
EP (1) EP0791012A1 (OSRAM)
JP (1) JPH09502427A (OSRAM)
KR (1) KR960702848A (OSRAM)
CN (1) CN1126999A (OSRAM)
AU (1) AU676071B2 (OSRAM)
CA (1) CA2163114A1 (OSRAM)
CZ (1) CZ9896A3 (OSRAM)
FI (1) FI960119A0 (OSRAM)
HU (1) HUT74874A (OSRAM)
IL (1) IL110267A0 (OSRAM)
NO (1) NO955059L (OSRAM)
PL (1) PL312568A1 (OSRAM)
SE (1) SE501678C2 (OSRAM)
TW (1) TW268009B (OSRAM)
WO (1) WO1995002609A1 (OSRAM)
ZA (1) ZA945090B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
DE60309847T2 (de) 2002-02-27 2007-10-18 Ferring B.V. Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
JP2018535946A (ja) 2015-10-06 2018-12-06 フェリング・ベー・フェー バルシバン及びその中間体を作製する新規の方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
AU676071B2 (en) 1997-02-27
WO1995002609A1 (en) 1995-01-26
TW268009B (OSRAM) 1996-01-11
IL110267A0 (en) 1994-10-21
HU9503768D0 (en) 1996-02-28
CZ9896A3 (en) 1996-06-12
SE9302414L (sv) 1995-01-14
PL312568A1 (en) 1996-04-29
SE9302414D0 (sv) 1993-07-13
NO955059D0 (no) 1995-12-13
AU7240694A (en) 1995-02-13
SE501678C2 (sv) 1995-04-10
CA2163114A1 (en) 1995-01-26
FI960119A7 (fi) 1996-01-10
ZA945090B (en) 1995-02-22
JPH09502427A (ja) 1997-03-11
CN1126999A (zh) 1996-07-17
KR960702848A (ko) 1996-05-23
HUT74874A (en) 1997-02-28
FI960119L (fi) 1996-01-10
EP0791012A1 (en) 1997-08-27
FI960119A0 (fi) 1996-01-10

Similar Documents

Publication Publication Date Title
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
NO982731L (no) Antagonister av gonadotropinfrigivende hormon
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
BRPI9708566A (pt) Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2.
CA2250420A1 (en) Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
MY139203A (en) Pharmaceutical composition
IL72018A (en) Biologically active heptapeptides structurally related to region within growth hormones and pharmaceutical compositions comprising them
RO118174B1 (ro) Lac de unghii şi utilizarea acestuia
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
SE9302124D0 (sv) Biologically active vasopressin analogues
TW324662B (en) Benzamide-containing pharmaceutical composition
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
NO955059L (no) Peptider som utviser oksytocin antagonistisk aktivitet
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
DE60031439D1 (de) Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
ES8701784A1 (es) Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью